Comparative in vitro activity of Mk-0366 and other selected oral antimicrobial agents against Neisseria gonorrhoeae
Open Access
- 1 August 1981
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 20 (2), 265-266
- https://doi.org/10.1128/aac.20.2.265
Abstract
The in vitro activity of a new ora antimicrobial agent, Mk-0366 (AM-715), was compared with those of rosoxacin, ampicillin, erythromycin, and tetracycline against Neisseria gonorrhoeae. Mk-0366 was as active as rosoxacin and more active than the other three antimicrobial agents. It inhibited all isolates, regardless of beta-lactamase activity, at a concentration of 0.03 micrograms/ml.This publication has 7 references indexed in Scilit:
- Comparative Activities of AM-715 and Pipemidic and Nalidixic Acids Against Experimentally Induced Systemic and Urinary Tract InfectionsAntimicrobial Agents and Chemotherapy, 1981
- In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strainsAntimicrobial Agents and Chemotherapy, 1980
- In Vitro Antibacterial Activity of AM-715, a New Nalidixic Acid AnalogAntimicrobial Agents and Chemotherapy, 1980
- Cefoxitin as a Single-Dose Treatment for Urethritis Caused by Penicillinase-ProducingNeisseria GonorrhoeaeNew England Journal of Medicine, 1979
- Clinical experience in the use of cefuroxime in gonorrhoea.Sexually Transmitted Infections, 1978
- The susceptibility of Neisseria gonorrhoeae to cefoxitin sodiumJournal of Antimicrobial Chemotherapy, 1978
- PENICILLINASE-PRODUCING NEISSERIA GONORRHήOEAThe Lancet, 1976